Mafalda Cacciottolo
About Mafalda Cacciottolo
Mafalda Cacciottolo serves as the Associate Director of R&PD at Capricor Therapeutics, Inc. in San Diego, California, bringing over 20 years of experience in molecular biology and genetics, particularly in preclinical studies.
Work at Capricor Therapeutics
Mafalda Cacciottolo serves as the Associate Director of Research and Product Development (R&PD) at Capricor Therapeutics, Inc. since 2023. She has previously held roles within the company, including Research Manager for Preclinical Studies from 2021 to 2023 and In Vivo Senior Scientist for a brief period in 2021. Her work involves close collaboration with Quality Control, Quality Assurance, and Regulatory departments, ensuring that projects meet necessary compliance and quality standards. Cacciottolo's extensive experience in molecular biology and genetics, particularly in preclinical studies, supports her leadership in managing complex, deadline-oriented projects.
Education and Expertise
Mafalda Cacciottolo holds a Doctor of Philosophy (PhD) in Medical Genetics from Seconda Università degli Studi di Napoli, which she obtained from 2007 to 2009. She also earned a Master's degree in Medical Biotechnology from Università degli Studi di Napoli Federico II between 2004 and 2006, and a Bachelor of Science (BSc) in Biotecnologie per la Salute from the same institution from 2001 to 2004. Cacciottolo possesses over 20 years of experience in molecular biology and genetics, with a particular focus on neurodegeneration diseases and immunology. Her expertise extends to exosome technology, including scalable production methods and targeted delivery systems.
Background in Research
Cacciottolo's research background includes significant roles at various institutions. She worked as a Research Associate at the University of Southern California's Davis School of Gerontology from 2015 to 2021 and held postdoctoral positions at the same university from 2011 to 2015. Earlier, she was a PhD student and researcher at TIGEM from 2005 to 2010. Additionally, she spent time as a guest PhD student at the Institute of Human Genetics in the UK in 2009. Her research has included studies on SARS-CoV-2 spike protein delivery via exosomes and the development of exosome-based vaccines and therapeutics.
Professional Experience
Mafalda Cacciottolo has accumulated extensive professional experience in the field of molecular biology and genetics. She has worked with Contract Research Organizations (CROs) to develop various projects and has authored multiple scientific publications on exosome technology and cell therapy. Her roles have included managing preclinical studies and collaborating on innovative research projects. Cacciottolo's leadership and organizational skills are crucial in her current position, where she oversees projects that require meticulous planning and execution.